Quarterly report pursuant to sections 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v2.4.0.8
Consolidated Balance Sheets (Unaudited) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Current assets:    
Cash $ 6,391,293 $ 2,354,169
Accounts receivable 250,000   
Marketable securities - available for sale securities 6,250 12,500
Prepaid expenses 445,925 40,333
Assets of discontinued operations - current portion    82,145
Total current assets 7,093,468 2,489,147
Other assets:    
Property and equipment, net 8,889   
Intangible assets, net 2,501,984 492,152
Goodwill 2,144,488   
Assets of discontinued operations - long term portion    1,035,570
Total other assets 4,655,361 1,527,722
Total Assets 11,748,829 4,016,869
Current liabilities:    
Accounts payable and accrued expenses 392,876 57,158
Liabilities of discontinued operations 30,664 30,664
Total liabilities 423,540 87,822
Stockholders' Equity:    
Preferred stock, $.0001 par value, 50,000,000 shares authorized: none issued and outstanding      
Common stock, $.0001 par value; 200,000,000 shares authorized; 5,167,988 and 3,503,565 issued and outstanding at June 30, 2013 and December 31, 2012 517 352
Additional paid-in capital 19,794,687 10,976,325
Accumulated other comprehensive income - marketable securities available for sale (6,250)   
Deficits accumulated during the development stage (8,453,169) (7,037,134)
Total Marathon Patent Group, Inc. equity 11,335,785 3,939,543
Non-controlling interest in subsidiary (10,496) (10,496)
Total stockholders' equity 11,325,289 3,929,047
Total liabilities and stockholders' equity $ 11,748,829 $ 4,016,869